The efficacy of moxifloxacin-based triple therapy in treatment of Helicobacter pylori infection: a systematic review and meta-analysis of randomized clinical trials

Recent evidence shows that moxifloxacin could exert an antimicrobial effect against Helicobacter pylori in both in vitro and in vivo models. To systematically evaluate whether moxifloxacin-containing triple therapy could improve eradication rates and reduce side effects in first-line or second-line...

Descripción completa

Detalles Bibliográficos
Autores principales: Zhang, G., Zou, J., Liu, F., Bao, Z., Dong, F., Huang, Y., Yin, S.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Associação Brasileira de Divulgação Científica 2013
Materias:
Clinical Investigation
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859334/
https://www.ncbi.nlm.nih.gov/pubmed/23903685
http://dx.doi.org/10.1590/1414-431X20132817

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3859334/
https://www.ncbi.nlm.nih.gov/pubmed/23903685
http://dx.doi.org/10.1590/1414-431X20132817

Ejemplares similares